OR WAIT null SECS
September 22, 2021
Article
A meta-analysis builds upon previous research and provides new insight into the total costs of diagnosis and treating PCOS as well as the costs of treating PCOS-related comorbidities.
September 14, 2021
An overlooked aspect of an under-discussed condition, Andrea Dunaif, MD, provided an overview of the cardiovascular risk seen among women with polycystic ovary syndrome.
July 19, 2021
Data from a phase 2 study of women with overweight or obesity and polycystic ovary syndrome suggests use of licogliflozin was associated with significant reductions in hyperinsulinemia and androgenemia in this patient population.
June 21, 2021
A pilot trial in 29 women suggests a combination of metformin and high dose fish oil could reduce triglycerides and ApoB-remnants among young women with polycystic ovary syndrome.
June 10, 2021
A comparison of women with PCOS to matched controls indicates women with PCOS were at a 26% greater risk of experiencing major adverse cardiovascular events than their counterparts without polycystic ovary syndrome.
March 22, 2021
A meta-analysis of nearly a dozen studies presented at ENDO 2021 suggests Black women with PCOS were at an increased cardiometabolic risk, despite having comparable fasting glucose and lower triglyceride levels.
March 20, 2021
An analysis of 4k transgender youth and 16k propensity-matched controls is providing insight into the increased risk of conditions adversely impacting the cardiometabolic health of these patients.
December 31, 2020
This article features the top 5 stories in Endocrinology Network's coverage of women's health during 2020.
October 15, 2020
An analysis of data from more than 9 million women details the increased odds of developing gestational diabetes, gestational hypertension, and other complications associated with having polycystic ovary syndrome.
September 10, 2020
New research suggests children born to mothers with PCOS could be at an increased risk of developing a psychiatric disorder later in life.
